The ongoing Iran war and the disruption of shipping through the Strait of Hormuz have triggered one of the most significant shocks to global pharmaceutical supply chains in decades. For…
Sun Pharmaceutical Industries, India’s largest drugmaker, has received approval from the South African Health Products Regulatory Authority (SAHPRA) to market a generic version of semaglutide injection. The approval marks a…
The landmark India-UK Comprehensive Economic Trade Agreement (CETA) came into effect on July 15, 2026, marking a new chapter for Indian pharmaceutical exports to Britain. The Pharmaceutical Export Promotion Council…
Indian pharmaceutical companies are executing a strategic pivot in 2026 — doubling down on specialty drugs and biosimilars through record-breaking M&A and US investment, while maintaining their core generics business…